| Secondary |
| Depression |
23.0% |
| Drug Use For Unknown Indication |
17.8% |
| Product Used For Unknown Indication |
10.4% |
| Drug Exposure During Pregnancy |
6.7% |
| Accidental Exposure |
4.4% |
| Intentional Overdose |
4.4% |
| Wegener's Granulomatosis |
4.4% |
| Pain |
3.7% |
| Helicobacter Infection |
3.0% |
| Sedation |
3.0% |
| Sepsis |
3.0% |
| Disease Recurrence |
2.2% |
| Restlessness |
2.2% |
| Schizophrenia |
2.2% |
| Thrombosis Prophylaxis |
2.2% |
| Amino Acid Level |
1.5% |
| Blood Glucose Decreased |
1.5% |
| Candidiasis |
1.5% |
| Coagulopathy |
1.5% |
| Contraception |
1.5% |
|
| Tachycardia |
24.4% |
| Suicide Attempt |
17.8% |
| Breast Enlargement |
8.9% |
| Long Qt Syndrome |
6.7% |
| Stevens-johnson Syndrome |
6.7% |
| Somnolence |
4.4% |
| Vasoconstriction |
4.4% |
| Weight Increased |
4.4% |
| Blood Prolactin Increased |
2.2% |
| Galactorrhoea |
2.2% |
| Hypokinesia |
2.2% |
| Leukopenia |
2.2% |
| Myoclonus |
2.2% |
| Presyncope |
2.2% |
| Rhabdomyolysis |
2.2% |
| Small For Dates Baby |
2.2% |
| Stupor |
2.2% |
| Tremor |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.1% |
| Drug Use For Unknown Indication |
8.8% |
| Hypertension |
7.8% |
| Depression |
5.8% |
| Pain |
5.5% |
| Supplementation Therapy |
5.4% |
| Chronic Obstructive Pulmonary Disease |
4.5% |
| Pancreatitis |
4.4% |
| Tumour Pain |
4.4% |
| Prophylaxis |
3.9% |
| Sleep Disorder |
3.7% |
| Psychotic Disorder |
3.6% |
| Schizophrenia |
3.2% |
| Nausea |
3.1% |
| Schizophrenia, Paranoid Type |
2.9% |
| Anxiety Disorder |
2.8% |
| Thrombosis Prophylaxis |
2.8% |
| Sedation |
2.6% |
| Borderline Personality Disorder |
2.4% |
| Restlessness |
2.3% |
|
| Pulmonary Embolism |
18.6% |
| Weight Increased |
11.3% |
| International Normalised Ratio Increased |
6.2% |
| Thrombocytopenia |
6.2% |
| Atrial Flutter |
5.2% |
| Hepatitis Acute |
5.2% |
| Tremor |
5.2% |
| Dyspnoea |
4.1% |
| Toxic Epidermal Necrolysis |
4.1% |
| Transaminases Increased |
4.1% |
| Withdrawal Syndrome |
4.1% |
| Aggression |
3.1% |
| Agranulocytosis |
3.1% |
| Deafness Neurosensory |
3.1% |
| Rapid Correction Of Hyponatraemia |
3.1% |
| Restlessness |
3.1% |
| Temperature Regulation Disorder |
3.1% |
| Vision Blurred |
3.1% |
| Breast Discharge |
2.1% |
| Dermatitis Allergic |
2.1% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
| Sleep Apnoea Syndrome |
100.0% |
|
